p.Arg72Pro polymorphism of P53 and breast cancer risk: a meta-analysis of case-control studies
Open Access
- 19 October 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Medical Genetics
- Vol. 21 (1), 1-11
- https://doi.org/10.1186/s12881-020-01133-8
Abstract
The effect of the p.Arg72Pro variant of the P53 gene on the risk of development ofbreast cancer remains variable in populations. However, the use ofstrategies such aspoolingage-matched controls with disease may provide a consistent meta-analysis. Our goal was to perform a meta-analysis in order to assess the association of p.Arg72Pro variant of P53 gene with the risk of breast cancer. Databases such as PubMed, Genetics Medical Literature, Harvard University Library, Web of Science and Genesis Library were used to search articles. Case-control studies with age-matched on breast cancer havingevaluated the genotype frequencies of the TP53 p.Arg72Pro polymorphism were selected. The fixed and random effects (Mantel-Haenszel) were calculated using pooled odds ratio of 95% CI to determine the risk of disease. Inconsistency was calculated to determine heterogeneity among the studies. The publication bias was estimated using the funnel plot. Twenty-one publications with 7841 cases and 8876 controls were evaluated in this meta-analysis. Overall, our results suggested that TP53 p.Arg72Pro was associated with the risk of breast cancer for the dominant model (OR = 1.09, 95% CI = 1.02–1.16, P = 0.01) and the additive model (OR = 1.09, 95% CI = 1.01–1.17, P = 0.03), but not for the recessive model (OR = 1.07, 95% CI = 0.97–1.18, P = 0.19). According to the ethnic group analysis, Pro allele was associated with the risk of breast cancer in Caucasians for the dominant model and additive model (P = 0.02), and Africans for the recessive model and additive model (P = 0.03). This meta-analysis found a significant association between TP53 p.Arg72Pro polymorphism and the risk of breast cancer. Individuals carrying at least one Pro allele were more likely to have breast cancer than individuals harboring the Arg allele.Keywords
Other Versions
Funding Information
- HBNU Fellowship Fogarty International Center and the National Institutes (D43 TW010543)
This publication has 72 references indexed in Scilit:
- p53 codon 72 polymorphism and breast cancer risk: A meta-analysisExperimental and Therapeutic Medicine, 2013
- Allelic heterogeneity and more detailed analyses of known loci explain additional phenotypic variation and reveal complex patterns of associationHuman Molecular Genetics, 2011
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Genome-wide association studies in diverse populationsNature Reviews Genetics, 2010
- Gene–environment-wide association studies: emerging approachesNature Reviews Genetics, 2010
- Polymorphisms of TP53 codon 72 with breast carcinoma risk: evidence from 12226 cases and 10782 controlsJournal of Experimental & Clinical Cancer Research, 2009
- Pathway based analysis of SNPs with relevance to 5-FU therapy: Relation to intratumoral mRNA expression and survivalInternational Journal of Cancer, 2008
- Importance of TP53 codon 72 and intron 3 duplication 16bppolymorphisms in prediction of susceptibility on breast cancerBMC Cancer, 2008
- Estrogen Carcinogenesis in Breast CancerThe New England Journal of Medicine, 2006
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986